ABT vs. GKOS: Abbott Laboratories vs. Glaukos Stock Comparison

November 11, 2026

How do Abbott Laboratories (ABT) and Glaukos (GKOS) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Abbott Laboratories (ABT) and Glaukos (GKOS) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Company profile comparison for Abbott Laboratories (ABT) and Glaukos (GKOS)
Profile Item	ABT	GKOS
Name	Abbott Laboratories	Glaukos Corp.
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Equipment
Market Capitalization	190.39 billion USD	13.28 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	March 17, 1980	June 25, 2015
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABT

GKOS

GSPC

Abbott Laboratories (ABT) vs. Glaukos (GKOS), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Abbott Laboratories (ABT) and Glaukos (GKOS). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Abbott Laboratories (ABT) and Glaukos (GKOS). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
Total Return (1Y)	-10.78%	179.91%
Total Return (3Y, Annualized)	7.79%	55.51%
Total Return (5Y, Annualized)	-0.79%	35.14%

Risk Profile

Drawdown History

ABT

GKOS

GSPC

Abbott Laboratories (ABT) vs. Glaukos (GKOS), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Abbott Laboratories (ABT) and Glaukos (GKOS). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
Volatility (1Y, Annualized)	28.48%	61.24%
Beta (5Y)	0.53	0.68
Max Drawdown (5Y)	-39.64%	-53.68%
Avg. Volume (3M)	8.74M	1.15M

Risk-Adjusted Performance

Risk-Return Positioning

ABT and GKOS are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
Sharpe Ratio (1Y)	-0.53	2.87
Sortino Ratio (1Y)	-0.76	5.93

Profitability

ROE (TTM)

Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Abbott Laboratories (ABT) reports 9.14%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

9.14%

Max: 47.61%
Q3: 14.36%
ABT: 9.14%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

GKOS

Health Care Equipment & Services industry group

-22.84%

Max: 47.61%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
GKOS: -22.84%
Min: -47.01%

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile Abbott Laboratories (ABT) reports 9.75%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

9.75%

Max: 29.35%
ABT: 9.75%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

GKOS

Health Care Equipment & Services industry group

-24.60%

Max: 29.35%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
GKOS: -24.60%
Min: -28.46%

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Both Abbott Laboratories (ABT) at 11.66% and Glaukos (GKOS) at 0.39% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

ABT

Health Care Equipment & Services industry group

11.66%

Max: 35.43%
Q3: 14.14%
ABT: 11.66%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

GKOS

Health Care Equipment & Services industry group

0.39%

Max: 35.43%
Q3: 14.14%
Median: 6.81%
GKOS: 0.39%
Q1: -0.28%
Min: -16.29%

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
ROE (TTM)	9.14%	-22.84%
ROA (TTM)	4.90%	-3.90%
Net Margin (TTM)	9.75%	-24.60%
Operating Margin (TTM)	11.66%	0.39%
Gross Margin (TTM)	57.17%	81.13%

Growth

Revenue Growth

Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while Abbott Laboratories (ABT) at 5.67% is closer to the peer norm — faster top-line expansion for GKOS.

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Abbott Laboratories (ABT) reports EPS growth of -51.31%, ranked against its industry; Glaukos (GKOS) has no EPS growth figure this period.

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
Revenue Growth (YoY)	5.67%	32.33%
Revenue Growth (3Y CAGR)	0.51%	21.51%
EPS Growth (YoY)	-51.31%	--
EPS Growth (3Y CAGR)	-1.65%	--

Financial Strength

Current Ratio (MRQ)

Abbott Laboratories (ABT) at 1.46 keeps current ratio within its industry’s typical mid-range, while Glaukos (GKOS) at 4.57 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

ABT

Health Care Equipment & Services industry group

1.46

Max: 7.59
Q3: 4.00
Median: 1.98
ABT: 1.46
Q1: 1.37
Min: 0.30

GKOS

Health Care Equipment & Services industry group

4.57

Max: 7.59
GKOS: 4.57
Q3: 4.00
Median: 1.98
Q1: 1.37
Min: 0.30

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Glaukos (GKOS) at 0.15 keeps leverage in the lower industry quartile, while Abbott Laboratories (ABT) at 0.61 runs a more typical debt-to-equity mix.

ABT

Health Care Equipment & Services industry group

0.61

Max: 1.88
Q3: 0.91
ABT: 0.61
Median: 0.58
Q1: 0.16
Min: 0.00

GKOS

Health Care Equipment & Services industry group

0.15

Max: 1.88
Q3: 0.91
Median: 0.58
Q1: 0.16
GKOS: 0.15
Min: 0.00

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
Current Ratio (MRQ)	1.46	4.57
Debt / Equity (MRQ)	0.61	0.15
Net Debt / EBITDA	2.37	--

Dividends

Dividend Yield (TTM)

Glaukos (GKOS) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

2.22%

ABT: 2.22%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

GKOS

Health Care Equipment & Services industry group

0.00%

GKOS: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Glaukos (GKOS) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

92.54%

ABT: 92.54%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

GKOS

Health Care Equipment & Services industry group

0.00%

GKOS: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
Dividend Yield (TTM)	2.22%	0.00%
Dividend Payout Ratio (TTM)	92.54%	0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Abbott Laboratories (ABT) trades at 41.02 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.

ABT

Health Care Equipment & Services industry group

41.02

Max: 80.41
Q3: 47.62
ABT: 41.02
Median: 29.93
Q1: 21.19
Min: 4.21

GKOS

Health Care Equipment & Services industry group

Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
Min: 4.21
GKOS: --

Abbott Laboratories (ABT) vs. Glaukos (GKOS): GKOS does not report P/E ratio, so it has no value marker; ABT is benchmarked against the Health Care Equipment & Services industry group.

P/S Ratio (TTM)

Abbott Laboratories (ABT) at 3.95 prices around its industry’s typical P/S ratio, while Glaukos (GKOS) at 19.24 clears its benchmark range — GKOS looks notably rich on sales.

ABT

Health Care Equipment & Services industry group

3.95

Max: 8.80
Q3: 4.32
ABT: 3.95
Median: 2.13
Q1: 1.10
Min: 0.03

GKOS

Health Care Equipment & Services industry group

19.24

GKOS: 19.24
Max: 8.80
Q3: 4.32
Median: 2.13
Q1: 1.10
Min: 0.03

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

Abbott Laboratories (ABT) at 3.73 sits near its industry’s typical P/B ratio, while Glaukos (GKOS) at 18.51 prices above its benchmark range — GKOS looks rich relative to book.

ABT

Health Care Equipment & Services industry group

3.73

Max: 11.68
Q3: 6.12
ABT: 3.73
Median: 3.00
Q1: 1.73
Min: -1.31

GKOS

Health Care Equipment & Services industry group

18.51

GKOS: 18.51
Max: 11.68
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31

Abbott Laboratories (ABT) vs. Glaukos (GKOS): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Abbott Laboratories (ABT) and Glaukos (GKOS)
Metric	ABT	GKOS
P/E Ratio (TTM)	41.02	--
P/S Ratio (TTM)	3.95	19.24
P/B Ratio (MRQ)	3.73	18.51
Free Cash Flow Yield (TTM)	3.19%	0.40%